248 related articles for article (PubMed ID: 25455139)
1. Influence of component 5a receptor 1 (C5AR1) -1330T/G polymorphism on nonsedating H1-antihistamines therapy in Chinese patients with chronic spontaneous urticaria.
Yan S; Chen W; Wen S; Zhu W; Guo A; Chen X; Zhang C; Chen M; Zhang J; Su J; Zhao Y; He Y; Liu Z; Zhou H; Zeng W; Li J; Chen X
J Dermatol Sci; 2014 Dec; 76(3):240-5. PubMed ID: 25455139
[TBL] [Abstract][Full Text] [Related]
2. Association of FCER1A genetic polymorphisms with risk for chronic spontaneous urticaria and efficacy of nonsedating H1-antihistamines in Chinese patients.
Guo A; Zhu W; Zhang C; Wen S; Chen X; Chen M; Zhang J; Su J; Chen W; Zhao Y; Yan S; He Y; Liu Z; Zhou H; Chen X; Li J
Arch Dermatol Res; 2015 Mar; 307(2):183-90. PubMed ID: 25412950
[TBL] [Abstract][Full Text] [Related]
3. [Association of CACNA1C gene genetic polymorphism with the susceptibility as well as prognosis for chronic spontaneous urticaria].
Yan J; Li Q; Luo Y; Yan S; He Y; Chen X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Sep; 43(9):929-936. PubMed ID: 30333282
[TBL] [Abstract][Full Text] [Related]
4. Human H1 receptor (HRH1) gene polymorphism is associated with the severity of side effects after desloratadine treatment in Chinese patients with chronic spontaneous uticaria.
Li J; Chen W; Peng C; Zhu W; Liu Z; Zhang W; Su J; Li J; Chen X
Pharmacogenomics J; 2020 Feb; 20(1):87-93. PubMed ID: 31406237
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein (CRP) rs3093059C predicts poor mizolastine response in chronic spontaneous urticaria patients with elevated serum CRP level.
Yan S; Chen W; Peng C; Zhu W; Chen M; Zhang J; Su J; Li F; Liu Z; Zhang W; Li Q; Li J; Chen X
Exp Dermatol; 2019 Mar; 28(3):240-246. PubMed ID: 30632650
[TBL] [Abstract][Full Text] [Related]
6. H1-antihistamines for chronic spontaneous urticaria.
Sharma M; Bennett C; Cohen SN; Carter B
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006137. PubMed ID: 25397904
[TBL] [Abstract][Full Text] [Related]
7. Association of ORAI1 gene polymorphisms with chronic spontaneous urticaria and the efficacy of the nonsedating H1 antihistamine desloratadine.
Li J; Guo A; Chen W; Bin L; He Y; Zhu W; Peng C; Yan S; Chen M; Zhang J; Su J; Yi M; Liu Z; Zhang W; Zeng W; Leung DY; Chen X
J Allergy Clin Immunol; 2017 Apr; 139(4):1386-1388.e9. PubMed ID: 27864023
[No Abstract] [Full Text] [Related]
8. Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years.
Potter P; Mitha E; Barkai L; Mezei G; Santamaría E; Izquierdo I; Maurer M
Pediatr Allergy Immunol; 2016 Feb; 27(1):55-61. PubMed ID: 26267219
[TBL] [Abstract][Full Text] [Related]
9. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.
DuBuske L
Am J Clin Dermatol; 2007; 8(5):271-83. PubMed ID: 17902729
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies.
Bachert C; Maurer M
Clin Drug Investig; 2010; 30(2):109-22. PubMed ID: 20067329
[TBL] [Abstract][Full Text] [Related]
11. H(1)-antihistamines and urticaria: how can we predict the best drug for our patient?
Church MK; Maurer M
Clin Exp Allergy; 2012 Oct; 42(10):1423-9. PubMed ID: 22994340
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of treatments for chronic spontaneous urticaria with inadequate response to licensed first-line treatments.
Mitchell S; Balp MM; Samuel M; McBride D; Maurer M
Int J Dermatol; 2015 Sep; 54(9):1088-104. PubMed ID: 25515967
[TBL] [Abstract][Full Text] [Related]
13. Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience.
Nettis E; Cegolon L; Di Leo E; Canonica WG; Detoraki A;
Ann Allergy Asthma Immunol; 2018 Mar; 120(3):318-323. PubMed ID: 29508719
[TBL] [Abstract][Full Text] [Related]
14. CRP relevance in clinical assessment of chronic spontaneous urticaria Tunisian patients.
Maouia A; Youssef M; Leban N; Ben Chibani J; Helal AN; Kassab A
Cutan Ocul Toxicol; 2017 Dec; 36(4):387-392. PubMed ID: 28351163
[TBL] [Abstract][Full Text] [Related]
15. Health care burden and treatment patterns in commercially insured children with chronic idiopathic/spontaneous urticaria: A real-world study in the United States.
Williams P; Kavati A; Pilon D; Xiao Y; Zhdanava M; Balp MM; Lefebvre P; Ortiz B; Hernandez-Trujillo V
Allergy Asthma Proc; 2018 May; 39(3):201-211. PubMed ID: 29514728
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of uncontrolled symptoms using the standard dose of second-generation H1 -antihistamines in chronic spontaneous urticaria children.
Koosakulchai V; Yuenyongviwat A; Sangsupawanich P
Asian Pac J Allergy Immunol; 2022 Jun; 40(2):121-125. PubMed ID: 32061244
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria.
Kolkhir P; Altrichter S; Hawro T; Maurer M
Allergy; 2018 Apr; 73(4):940-948. PubMed ID: 29130488
[TBL] [Abstract][Full Text] [Related]
18. Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial.
Staevska M; Gugutkova M; Lazarova C; Kralimarkova T; Dimitrov V; Zuberbier T; Church MK; Popov TA
Br J Dermatol; 2014 Jul; 171(1):148-54. PubMed ID: 24472058
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial.
Fukunaga A; Oda Y; Washio K; Omori T; Kakei Y; Hide M; Nishigori C
Trials; 2020 Jan; 21(1):23. PubMed ID: 31906999
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Autologous Whole-Blood Injections in Patients with Refractory Chronic Spontaneous Urticaria.
Kitsioulis NA; Xepapadaki P; Roussaki-Schulze AV; Papadopoulos N; Zafiriou E
Int Arch Allergy Immunol; 2017; 172(3):161-166. PubMed ID: 28380487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]